The life sciences supply chain:
Insights around drug shortages, production capacity and speed to market
The life sciences supply chain: insights around drug shortages...
- Rethinking Resilience supply chain podcast
- By Resilinc
- APR 16, 2024
Approximately 86-90%1 of professionals confirmed in 2023 the daily challenges associated with ongoing drug shortages which continue to impact the ability to provide safe, high-quality patient care. The numbers speak volumes within the global life sciences supply chain in terms of today’s scenarios of drug rationing, alternative medication provisions and even delayed patient treatment. Data from the Biden-Harris Administration2 cites a U.S. shortage of 15 cancer drugs due to manufacturing quality issues and supply chain disruptions.
In this episode, hear Antonio Menendez-Rodriguez and Anderson Ip discuss how they’re navigating the current life sciences supply chain landscape of drug shortages amidst ongoing Russia-Ukraine and Hamas-Israel wars and geopolitical tensions, supply gaps, and import/export restrictions.
1:14 | Factors contributing to life science drug shortages
5:34 | Understanding the end-to-end patient journey
7:00 | Managing risks and impacts of geopolitical tensions
7:39 | Increasing supplier and inventory visibility
8:35 | Partnerships between regulators and life science authorities
12:12 | Public-private sector collaboration
13:35 | Life science supply chain purchasing best practices
14:30 | Supply chain resilience and keeping the patient first
Reference:
Speakers
Antonio Menendez-Rodriguez
Vice President of Commercial Supply Chain, Exelixis
With Exelixis for three years, Antonio holds more than 25 years of experience in supply chain, specifically in the pharma/bio industry. Previously, he served as the head of commercial supply chain for Aimmune Therapeutics and held past roles within Genentech, and Merck & Co.
Anderson Ip
15-year pharmaceutical veteran, Life sciences industry
A seasoned pharmaceutical leader, Anderson is dedicated to positively impacting and continuously improving patient experience. His expertise spans across cell therapy, biologics, and small molecule environments and includes extensive optimization expertise across supply chain, team and lead time performance. Previously, he served as Director, Global Supply Chain and Network Planning for Instil Bio. He has held past leadership roles at Roche and Genentech.
Craig Fix
Senior Director of Customer Success, Resilinc
Craig serves as Resilinc's Senior Director of Customer Success, with a focus on the company’s life sciences, healthcare and pharma customers. Prior to joining Resilinc, Craig spent nearly 30 years as a global procurement and supply chain leader in both the high tech and life sciences industries, this includes eight years at the world’s largest dental products company where he was responsible for global procurement. After the Japan earthquake and tsunami disaster in 2011, Craig partnered with Resilinc on a supply risk management and mitigation strategy leading to better sub-tier visibility and the ability to respond faster to risk events.
About the podcast
Each quarter, Resilinc’s Rethinking Resilience: supply chain podcast features global practitioners and leaders to discuss industry developments driving the need for greater global supply chain resiliency and agility, and transparent supply and demand continuity. Listen in as our speakers define what supply chain resiliency means to them and their organizations. Hear them tackle challenging ‘sticky’ topics required for holistic supply chain growth and innovation. Gain insights, best practices, learnings and tactics today’s supply chain visionaries use to address the current and future state of global supply chain and drive their organizational success.
- Production and manufacturing
- Workforce and skilled talent
- Regulatory governance/policy compliance
- Sustainability/ESG initiatives
- Cost/ROI of resilience
- Buyer-supplier relationships
- Sourcing and procurement
